{"organizations": [], "uuid": "a90a9265b946d5a69e4fbf86b2afbe88180761a7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180424.html", "section_title": "Archive News &amp; Video for Tuesday, 24 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sofinnova-partners-leads-erydels-2/brief-sofinnova-partners-leads-erydels-26-5-million-financing-idUSFWN1S102I", "country": "US", "domain_rank": 408, "title": "BRIEF-Sofinnova Partners leads Erydel’s €26.5 million financing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.503, "site_type": "news", "published": "2018-04-24T14:07:00.000+03:00", "replies_count": 0, "uuid": "a90a9265b946d5a69e4fbf86b2afbe88180761a7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sofinnova-partners-leads-erydels-2/brief-sofinnova-partners-leads-erydels-26-5-million-financing-idUSFWN1S102I", "ord_in_thread": 0, "title": "BRIEF-Sofinnova Partners leads Erydel’s €26.5 million financing", "locations": [], "entities": {"persons": [{"name": "erydel", "sentiment": "negative"}], "locations": [{"name": "asia", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}, {"name": "europe", "sentiment": "none"}, {"name": "australia", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-sofinnova partners", "sentiment": "negative"}, {"name": "sofinnova partners", "sentiment": "negative"}, {"name": "life sciences", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "innogest sgr", "sentiment": "none"}, {"name": "genextra spa", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Sofinnova Partners:\n* Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced today it has led EryDel’s €26.5 M financing\n* The Italian biotech company, which specializes in drug delivery through red blood cells, will be using funds to boost its international development and to complete the ATTEST trial - a registrational Phase III clinical trial currently enrolling in Europe, Asia, Australia and in the United States\n* Existing shareholders Genextra SpA and Innogest SGR also participated to the investment\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-04-24T14:07:00.000+03:00", "crawled": "2018-04-25T14:19:52.016+03:00", "highlightTitle": ""}